Invitris
Redefining biotechnology with cell-free protein synthesis
Invitris is a biotechnology company specializing in cell-free protein synthesis, offering both prokaryotic and mammalian expression systems for research and development. Their platform enables rapid design, expression, and scalable production of complex proteins without the limitations of cell-based systems. They partner with life sciences organizations to tackle R&D challenges across multiple industry sectors.
Invitris provides prokaryotic and mammalian cell-free expression systems using their Phactory™ reagents, enabling faster protein synthesis with high tunability and scalable production.
life sciences researchers and biotechnology R&D teams
Background.
- Status
- launched
- Business model
- unknown
- Company
- Invitris
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.